Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-23-075939

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Loren Stefan Director 2023-06-28 Grant or award · Stock option (right to buy) +25,000 47,885 D
Loading xslF345X04/tm2320030-3_4seq1.xml…